ResearchViews Home
Login
Registration
Home
Latest News
Latest Deals
Report Store
Contact Us
Sign up for our FREE Weekly
Metabolic Disorders
ResearchViews Update.
Please enter your email address below
*
:
Related Industries
Pharma
Cardiovascular
Central Nervous System
Dermatology
ENT Disorders
Gastroenterology
Genito Urinary System and Sex Hormones
Hematology Disorders
Hormonal Disorders
Immunology
Infectious Disease
Male Health
Metabolic Disorders
Mouth and Dental Disorders
Musculoskeletal
Oncology
Ophthalmology
Respiratory
Women's Health
Medical
Cardiovascular Devices
Dental Devices
Diabetes Care Devices
Diagnostic Imaging
Drug Delivery Devices
Endoscopy Devices
ENT Devices
Healthcare IT
Hospital Supplies
In Vitro Diagnostics
Nephrology and Urology Devices
Neurology Devices
Ophthalmic Devices
Orthopedic Devices
Patient Monitoring
Respiratory Devices
Surgical Equipment
Wound Care Management
"
"
Click Here
Free Research Papers
Latest Metabolic Disorders Reports
Latest Metabolic Disorders Deals
Spherix Announces Private Placement Of Shares For $1.2 Million
Published: Feb 02 2012
Valeant Pharma Acquires Sports Nutrition Products Company, Probiotica Laboratorios, For $86 Million
Published: Feb 01 2012
Generex Biotechnology Announces Private Placement Of Units For $2 Million
Published: Jan 31 2012
MannKind Prices Public Offering Of Units For $50 Million
Published: Jan 31 2012
KineMed Enters Into Co-Development Agreement With Pfizer
Published: Jan 30 2012
Latest Metabolic Disorders News
Cytomedix Appoints David E Jorden As Executive Chairman
Date of story: Feb 03 2012
GENFIT's GFT505-210-6 Phase II Clinical Study Reaches All Primary And Secondary Efficacy Objectives
Date of story: Feb 03 2012
Prometheus Laboratories Appoints Anthony Yost As Senior Vice President And Chief Commercial Officer
Date of story: Feb 03 2012
Boehringer Ingelheim, GWT And TU Dresden Sign Diabetes Research Collaboration
Date of story: Feb 03 2012
Dr. Reddy’s Reports Revenue Of $522m In Q3 Fiscal 2012
Date of story: Feb 03 2012
Latest Metabolic Disorders Reports
Type II Diabetes Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020
By: GlobalData, Published: Mar-2012
Actos (Type 2 Diabetes) – Analysis and Forecasts to 2020
By: GlobalData, Published: Feb-2012
Aleglitazar (Type 2 Diabetes) – Analysis and Forecasts to 2020
By: GlobalData, Published: Feb-2012
Amaryl (Type 2 Diabetes) – Analysis and Forecasts to 2020
By: GlobalData, Published: Feb-2012
Apidra (Type 2 Diabetes) – Analysis and Forecasts to 2020
By: GlobalData, Published: Feb-2012